Construction and validation of clinical contents for development of learning objects.
CONCLUSION: The steps taken in the construction and validation of the content for the production of educational material for patients with head and neck cancer were adequate, relevant and suitable for use in other subjects. PMID: 29412287 [PubMed - in process]
Conclusions This report shows a single institution results of oncological treatment in patients with malignant salivary gland tumors, where positive surgical margins strongly correlate with patients’ worse outcome. Whether to extend the procedure, which very often requires sacrificing the nerve is still a question of debate.
My next blog post will be entitled " The Lie of Precision Medicine "— sarcastic_f (@sarcastic_f)June 23, 2018This post will be my own personalized rant about the false promises of personalized medicine. It will not be about neurological or psychiatric diseases, the typical topics for this blog. It will be about oncology, for very personal reasons: misery, frustration, and grief. After seven months of research on immunotherapy clinical trials, I couldn't find a single [acceptable] one1 in either Canada or the US that would enroll my partner with stage 4 cancer. For arbitrary reasons, for financial reaso...
We present our results in patients with recurrent H&N cancers treated with interstitial HDRBT in terms of survival and toxicity outcomes and also assess the prognostic factors associated with reirradiation with HDR Brachytherapy.
The treatment of recurrence of head and neck cancer after radiotherapy is very difficult. Surgery and re-irradiation can only be used in a few patients. The purpose of this study is to analyze the efficacy and safety of radioactive I-125 seeds implantation in the treatment of recurrent head and neck tumors after radiotherapy.
High dose-rate interstitial brachytherapy (HDRBT) at our institution has been limited to an extremely selected group of patients with heterogeneous head and neck (HN) cancers due to significant concerns for its toxicity profile. Our HDRBT technique in HN cancers differs from that of many other institutions in that our treatments are planned based on CT images and optimized using inverse planning simulated annealing (IPSA), which allows us to deliver higher doses per fraction than most reports in the literature.
To investigate the effect of external fixator in posture fixation during the interstitial of 125I seeds implantation for head and neck cancer under CT guidance.
The aim of this study was to assess the presence of enamel craze lines (ECL), part of the spectrum of the so called cracked tooth syndrome, in the surface of teeth irradiated in vivo.
Conclusion: In our experience, ALT and RFF demonstrated analogous practicability and reliability for the reconstruction of head and neck soft-tissue defects, with similar local and systemic complications and donor-site morbidity rates.
Conclusion Increased incidence of ECL may indicate weakened enamel structure in irradiated teeth, which might play a role in the onset and progression of RRC.
[Image from unsplash.com]From Accuray’s India approval to Masimo and PositiveID launching a Bluetooth-enabled thermometer, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. India approves Accuray’s Radixact X9 radiation therapy device Accuray announced in a June 21 press release that it has received an Atomic Energy Regulatory Board Type Approval in India for its Radixact X9 System. The approval allows the company to sell the TomoTherapy platform while allowing hospitals throughout India to import the system. The Radixact and TomoTherapy Systems are radiation th...